Myriad Women’s Health

Myriad Women’s Health is a genetic screening and testing company. Its product offerings include hereditary cancer tests as well as carrier and prenatal screening.

Employee Rating

3.8More
TypeSubsidiary
Parent CompanyMyriad Genetics
HQSouth San Francisco, US
Founded2018
Websitemyriadwomenshealth.com
Myriad Women’s Health was founded in 2018 and is headquartered in South San Francisco, US

Viewing summary data as a guest

Sign up for free to see all data

Myriad Women’s Health Office Locations

Myriad Women’s Health has an office in South San Francisco
South San Francisco, US (HQ)
180 Kimball Way
Show all (1)

Myriad Women’s Health Financials and Metrics

Summary Metrics

In total, Myriad Women’s Health had raised $171.6 m. Myriad Women’s Health is a subsidiary of Myriad Genetics

Myriad Women’s Health Revenue

Myriad Women’s Health's revenue was reported to be $123.99 m in FY, 2017
Annual
USDFY, 2017

Revenue

124.0m

Cost of goods sold

55.3m

Gross profit

68.7m

Gross profit Margin, %

55%
Quarterly
USDQ1, 2018

Revenue

102.6m

Cost of goods sold

44.8m

Gross profit

57.8m

Gross profit Margin, %

56%
Annual
USDFY, 2017

Cash

34.0m

Accounts Receivable

16.2m

Prepaid Expenses

3.6m

Inventories

3.9m
Quarterly
USDQ1, 2018

Cash

23.7m

Accounts Receivable

21.7m

Inventories

3.8m

Current Assets

53.8m
USDFY, 2017

Net Income

(37.3m)

Depreciation and Amortization

7.7m

Inventories

(801.0k)

Accounts Payable

2.3m
Show all financial metrics

Myriad Women’s Health Operating Metrics

Mar, 2017Jan, 2018

Genetic Counseling Sessions

75 k

Healthcare Professionals Served

10 k17 k

People Screened to Date

750 k850 k
Show all operating metrics

Myriad Women’s Health Revenue Breakdown

Embed Graph

Myriad Women’s Health revenue breakdown by business segment: 9.8% from Revenue from tests billed through out-of-network payers, 15.0% from Revenue from tests billed through laboratory service intermediaries, 74.4% from Revenue from tests billed through in-network payers and 0.8% from Other

Myriad Women’s Health Online and Social Media Presence

Embed Graph

Myriad Women’s Health News and Updates

Myriad Announces Closing of Counsyl Acquisition

Transformational Acquisition Enhances Myriad’s Leadership Position in Women’s Health Transformational Acquisition Enhances Myriad’s Leadership Position in Women’s Health

Genetic Testing 2018 Global Market Key Players - GeneDx, Invitae, Pathway Genomics Counsyl, Asper Biotech, Courtagen Life Sciences -Analysis And Forecast To 2025

Wiseguyreports.Com Adds “Genetic Testing – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2025” To Its Research Database. Posted via Industry Today. Follow us on Twitter @IndustryToday

Myriad Women’s Health Blogs

Patient Conversations: Help patients wrap their heads around carrier screening by grouping conditions into four categories

The Foresight™ Carrier Screen includes over 175 inherited conditions. Even if you had time to discuss each condition with your patient prior to screening, doing so would probably overwhelm or confuse her. Instead of focusing on individual conditions, it can be useful to describe them as falling into…

Sunset of the Reliant Cancer Screen

As you may have heard, Counsyl recently merged with Myriad Genetics, Inc. and is now Myriad Women’s Health, Inc., a premier genetic screening and personalized medicine testing company. We have always had mutual respect and admiration for each others’ dedication to patient care and quality. We are ex…

Announcement: Counsyl transitioning to Myriad Women’s Health, Inc.

Counsyl is proud to announce that our acquisition closed on July 31, 2018 and we have officially combined with Myriad Preventative Care to form Myriad Women’s Health, Inc., a premier women’s health genetic screening and testing company, and new business unit within Myriad. Together, we remain commit…

Peace of Mind, with Counsyl

Abby Eblen, MD shares how she helps her patients find answers and navigate the genetic screening process Disclaimer: Guest post by: Abby Eblen, MD, Fertility and IVF Specialist at Nashville Fertility Center and member of Counsyl’s speakers bureau Charting a Path for Couples Struggling with Infertili…

Better Access to Genetic Screening for Your Patients

Counsyl is committed to making genetic screening accessible for your patients through Counsyl Complete™, our comprehensive suite of support services. This is why, we are proud to announce two new improvements to help more patients access genetic screening:   1) New Ability to Ship Patient Saliva Kit…

Our Family’s Journey with Sickle Cell Disease

Q&A with Aishwarya Arjunan, MS, MPH, CGC, Clinical Product Specialist of Carrier Screening, Counsyl. June 19th is World Sickle Cell Day.  We sat down with Andrea Matthews, a parent of a child with sickle cell disease to share her family’s journey with this disease. If you’re unfamiliar with sick…
Show more

Myriad Women’s Health Frequently Asked Questions

  • When was Myriad Women’s Health founded?

    Myriad Women’s Health was founded in 2018.

  • What is Myriad Women’s Health revenue?

    Latest Myriad Women’s Health annual revenue is $124 m.

  • Who are Myriad Women’s Health competitors?

    Competitors of Myriad Women’s Health include 23andMe, Melbourne IVF and Future Family.

  • Where is Myriad Women’s Health headquarters?

    Myriad Women’s Health headquarters is located at 180 Kimball Way, South San Francisco.

  • Where are Myriad Women’s Health offices?

    Myriad Women’s Health has an office in South San Francisco.

  • How many offices does Myriad Women’s Health have?

    Myriad Women’s Health has 1 office.